Filter
93
Filtered Results: 93
Text search:
Comirnaty
Featured
Recommendations
16
New Publications
1
Language
Document type
Guidelines
37
Fact sheets
24
Studies & Reports
12
No document type
5
Manuals
3
Infographics
3
Online Courses
3
Strategic & Response Plan
3
Training Material
1
Brochures
1
Situation Updates
1
Countries / Regions
Germany
12
Argentina
8
Ukraine
7
Brazil
7
Russia
5
Benin
4
China
3
Middle East and North Africa
3
South Africa
3
Central African Republic
3
Mozambique
2
Latin America and the Carribbean
2
Eastern Europe
2
Ecuador
2
Kazakhstan
1
Global
1
Africa
1
Congo, Democratic Republic of
1
Western and Central Europe
1
Paraguay
1
France
1
Tunisia
1
Belarus
1
East and Southern Africa
1
Chad
1
Authors & Publishers
Publication Years
Category
Countries
49
Clinical Guidelines
2
Pharmacy & Technologies
2
Women & Child Health
1
Key Resources
1
Toolboxes
COVID-19
62
Refugee
9
AMR
2
Rapid Response
1
Ebola & Marburg
1
Pharmacy
1
Conflict
1
A rapid evidence briefing. Vaccinated people are less likely to develop long COVID, even if they get infected, a rapid review of 15 studies by the UK Health Security Agency shows.
COVID-19 & Vaccination
recommended
Issue Brief no.8. January 18,2021
Vaccination against the spread of the SARS-CoV-2 virus represents a milestone in the fight against the pandemic. Good communication and education of the population is essential for the success of the vaccination. Below is some information on vaccination strategies,...
El siguiente manual se continuará actualizando, de ser necesario, a medida que se disponga de nueva información.
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
This training module is designed to equip HWs with knowledge and communication skills to build their confidence and support them in their ability to promote acceptance of COVID-19 vaccination among other HWs.
Covid-19 Epidemiological Surveillance Guide: Public Health Emergency of National Importance for Coronavirus Disease 2019 - version 4
La evidencia disponible a nivel internacional sobre el uso de un segundo refuerzo muestra una mayor duración de la respuesta inmune y una disminución de la internación y la mortalidad por COVID 19 en la población de adultos mayores y huéspedes inmunocomprometidos. Por otra parte, el personal de...
interim guidance, 19 July 2021 (arabic version)
Campaña Nacional de Vacunación contra la COVID-19
(Last Update: July 2022)
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan...
La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a partir de los 6 años.
Many critical questions remain about the effectiveness of COVID-19 vaccines in real-world settings. These questions can only be answered in post-introduction vaccine effectiveness studies.This guidance document outlines an approach to leverage existing surveillance systems for Severe Acute Respirato...
Vacunación frente a la COVID 19: guía de suministro y logística: orientación provisional, 12 febrero de 2021
recommended
12 February 2021
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i...
COVID-19 Situation Update OPS/WHO Argentina: 10 February 2022
Situation report generated by the OPS/WHO representation in Argentina
updated version: 04/10/2021
Information about vaccine administration
